Bristol Myers Squibb had a punishing first quarter. It's undergoing a new cost-cutting campaign as a result. It won't have much capital to spare for investors or growth for a while. But I wouldn't ...

Aurora Cannabis has three big strikes against it. The Canada-based cannabis company does have a few good things going for it, though. The biggest knock against Aurora is that there are plenty of other ...